Inovio Pharmaceuticals Inc (NASDAQ:INO)

4.20
Delayed Data
As of Feb 16
 +0.09 / +2.19%
Today’s Change
3.76
Today|||52-Week Range
9.86
+1.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues8.5M10.4M20.4M2.6M
 
 
 
 
 
Depreciation And Amortization824.3K928.6K902.6K1.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses30.1M31.4M29.1M30.7M
 
 
 
 
 
Research And Development23.9M24.5M23.9M25.5M
 
 
 
 
 
Total Operating Expenses30.9M32.3M30.0M31.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.4M-21.9M-9.6M-29.2M
 
 
 
 
 
Extraordinary Credit--116.5K0.00423.3K
 
 
 
Extraordinary Charge-4.1M0.00-312.5K--
 
 
 
Other Expenses191.5K-1.3M469.1K-5.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.2M-23.1M-9.5M-34.1M
 
 
 
 
 
Net Income-26.2M-23.1M-9.5M-34.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.1M74.2M75.4M87.0M
 
 
 
 
 
Shares To Calculate EPS Diluted74.1M74.3M75.4M87.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.36-$0.31-$0.13-$0.39
 
 
 
 
 
EPS Diluted-$0.35-$0.31-$0.13-$0.39